BiotechTube
Home/Pipeline/APA-1000 Breast Thermotherapy System

APA-1000 Breast Thermotherapy System

Breast Cancer

Phase IIIPivotal Trial Approved (IDE/ITA)NCT01204801

Key Facts

Indication
Breast Cancer
Phase
Phase III
Status
Pivotal Trial Approved (IDE/ITA)
Company
Medifocus

About Medifocus

Medifocus Inc. is a public medical technology company with a mission to improve standards of care through its proprietary focused heat platforms. Its strategy leverages a revenue-generating, FDA-approved device for BPH (Prolieve®) to fund the clinical development of its late-stage Adaptive Phased Array (APA-1000) system for breast cancer. The company has established a robust intellectual property portfolio with approximately 100 patents and has secured regulatory approvals to initiate a pivotal Phase III trial for its oncology asset.

View full company profile

Therapeutic Areas

OncologyUrology

Other Breast Cancer Drugs

DrugCompanyPhase
Antifibrotic Therapy ProgramMeCo DiagnosticsPre-clinical
inPROBE for HER2SDS OpticClinical Investigation
Unnamed Breast Cancer ProgramClick TherapeuticsPilot/Phase 2
Lerociclib (Lerocliclib)Chemogenics BioPharmaPhase 3
AT-017Asieris PharmaceuticalsNot Specified
CDK2 inhibitorAcelleraPre-clinical
NP-G2-044Novita PharmaceuticalsPhase 2a
GCT-007Global Cancer TechnologyResearch
NDESContinuity BiosciencesPre-clinical
INP12InnoUpClinical
Dedicated Breast Radiotherapy SystemEhmet HealthCommercial
Liposome ProgramNanoTech PharmaPreclinical/Phase 1/2